Home / Community / News / News

News

11/13/2017 - 11:25am

Genetic and epigenetic mechanisms drive differences between CDM and DM1—a new study elucidates downstream signaling pathways that underlie their diverse phenotypes and represent putative therapy development targets for CDM.

11/13/2017 - 11:19am

Age and gender impact the onset and progression of DM2, but the pattern shows both similarities and differences from that of DM1.

10/23/2017 - 12:23pm

A new literature review suggests meta-analysis of cognitive studies in DM1 is both feasible and can inform understanding of disease mechanisms and patient management.

10/23/2017 - 12:20pm

It would be easy to conclude that insulin resistance and diabetes in myotonic dystrophy is a product of mis-splicing of INSR transcripts—but is that the full story?

08/15/2017 - 10:49am

Learn more about Dr. Ami Mankodi, principal investigator at the National Institutes of Health’s (NIH) National Institute of Neurological Disorders and Stroke (NINDS) in Bethesda, Maryland. Dr. Mankodi has been involved in research that has helped shape a fundamental biologic and molecular understanding of myotonic dystrophy (DM).

Partners

ExpansionTherapeutics.png

© Myotonic Dystrophy Foundation. All rights reserved.